415 related articles for article (PubMed ID: 18190320)
1. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
Vyas JM; Telford SR; Robbins GK
Clin Infect Dis; 2007 Dec; 45(12):1588-90. PubMed ID: 18190320
[TBL] [Abstract][Full Text] [Related]
2. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone and azithromycin treatment for babesiosis in an infant.
Raju M; Salazar JC; Leopold H; Krause PJ
Pediatr Infect Dis J; 2007 Feb; 26(2):181-3. PubMed ID: 17259886
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone and azithromycin for the treatment of babesiosis.
Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A
N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.
Wudhikarn K; Perry EH; Kemperman M; Jensen KA; Kline SE
Am J Med; 2011 Sep; 124(9):800-5. PubMed ID: 21683324
[TBL] [Abstract][Full Text] [Related]
6. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.
Häselbarth K; Tenter AM; Brade V; Krieger G; Hunfeld KP
Int J Med Microbiol; 2007 Jun; 297(3):197-204. PubMed ID: 17350888
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
[TBL] [Abstract][Full Text] [Related]
8. Persistent and relapsing babesiosis in immunocompromised patients.
Krause PJ; Gewurz BE; Hill D; Marty FM; Vannier E; Foppa IM; Furman RR; Neuhaus E; Skowron G; Gupta S; McCalla C; Pesanti EL; Young M; Heiman D; Hsue G; Gelfand JA; Wormser GP; Dickason J; Bia FJ; Hartman B; Telford SR; Christianson D; Dardick K; Coleman M; Girotto JE; Spielman A
Clin Infect Dis; 2008 Feb; 46(3):370-6. PubMed ID: 18181735
[TBL] [Abstract][Full Text] [Related]
9. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
[TBL] [Abstract][Full Text] [Related]
10. [Babesiosis in an immunocompromised German patient].
Häselbarth K; Kurz M; Hunfeld KP; Krieger G
Med Klin (Munich); 2008 Feb; 103(2):104-7. PubMed ID: 18270666
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy against babesiosis.
Vial HJ; Gorenflot A
Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
[TBL] [Abstract][Full Text] [Related]
12. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.
Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y
Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
[TBL] [Abstract][Full Text] [Related]
14. Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
Arsuaga M; González LM; Padial ES; Dinkessa AW; Sevilla E; Trigo E; Puente S; Gray J; Montero E
Emerg Infect Dis; 2018 Aug; 24(8):1588-1589. PubMed ID: 30016247
[TBL] [Abstract][Full Text] [Related]
15. Congenital babesiosis in a four-week-old female infant.
Aderinboye O; Syed SS
Pediatr Infect Dis J; 2010 Feb; 29(2):188. PubMed ID: 20118748
[No Abstract] [Full Text] [Related]
16. Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host.
Cunha BA; Cohen YZ; McDermott B
Heart Lung; 2008; 37(6):481-4. PubMed ID: 18992633
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated babesiosis in a 7-month-old infant after bidirectional Glenn procedure.
Nicholson GT; Walsh CA; Madan RP
Congenit Heart Dis; 2010; 5(6):607-13. PubMed ID: 21106022
[TBL] [Abstract][Full Text] [Related]
18. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
Jefferies R; Ryan UM; Jardine J; Robertson ID; Irwin PJ
Exp Parasitol; 2007 Oct; 117(2):115-23. PubMed ID: 17543304
[TBL] [Abstract][Full Text] [Related]
19. Babesiosis in humans: a treatment review.
Weiss LM
Expert Opin Pharmacother; 2002 Aug; 3(8):1109-15. PubMed ID: 12150690
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
Pudney M; Gray JS
J Parasitol; 1997 Apr; 83(2):307-10. PubMed ID: 9105316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
